thymosin beta-4 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-09-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
As of 2024, the Coffee Bean and Tea Leaf has a total of 1,232 stores in 24 countries, including Bahrain, Bangladesh, Brunei, India, Indonesia, Israel, Jordan, Kingdom of Saudi Arabia, Kuwait, Kurdistan, Malaysia, Mongolia, Myanmar, Oman, Pakistan, Panama, Paraguay, Philippines, Qatar, Singapore, South Korea, Sri Lanka, USA, and Vietnam.
=== Non surgical === Non surgical treatment may be attempted before surgery as first line treatment. Where surgery has clear indications (e.g., high grade IRS which is causing incontinence), surgery may be considered without attempting non surgical treatment. Oxford grade I-III IRP without incontinence are usually suitable for non surgical treatment rather than surgery. Similarly, Oxford grade IV IRP in individuals who have high risk for surgery for unrelated reasons. Symptoms of obstructed defecation in IRP may be more responsive to non surgical treatment measures compared to other symptoms. The general aim of non surgical treatments is to normalize bowel habits. Symptomatic IRP rarely improves with conservative measures like laxatives and enemas. According to one report about a third of patients experience partial improvement of symptoms with conservative treatment, while two thirds had zero improvement or even worsening of symptoms. Another source stated that constipation improves with conservative measures alone in over half of cases of IRP.
However, the extent to which these concepts, developed for macro-eukaryotes, can be applied to prokaryotes with their different lifestyles regarding dormancy, variation of phenotype, and horizontal gene transfer as well as to micro-eukaryotes that is not quite clear. This raises the challenge of considering an entirely novel body of conceptual ecology models and theory for microbiome ecology, particularly in relation to the diverse hierarchies of interactions of microbes with one another and with the host biotic and abiotic environments. Many current definitions fail to capture this complexity and describe the term microbiome as encompassing the genomes of microorganisms only.
== Death == On March 24, 2010, Culp died at age 79 of a head injury sustained from a fall while walking near Runyon Canyon Park in Los Angeles; although Culp had apparently suffered a heart attack which caused the fall, it was the head injury that was fatal. He is buried at Sunset View Cemetery in El Cerrito. A memorial service was held at Grauman's Egyptian Theater in Los Angeles on April 10, 2010. At the time of his death, Culp had just completed performing a supporting role as Blakesley in the film The Assignment. He was also working on several screenplays, including an adaptation of the story of Terry and the Pirates that had already been accepted for filming and was scheduled to start production in Hong Kong in 2012, with Culp directing. Terry and the Pirates had been Culp's favorite comic strip as a boy, and it was his longtime wish to make a film based on it.
Sources: en.wikipedia.org
==== Initial campaigns (October–December 1932) ==== Liu Wenhui was taken off-guard by the sudden war; in contrast, Liu Xiang had developed a strategy of cutting his uncle's supply lines. Liu Xiang's forces would first attack Luzhou in a combined arms offensive featuring his army, navy, and aviation, capturing the city. After the loss of Luzhou, an uprising broke out in Yibin against the rule of Liu Wenhui and his extractive tax collector and brother Liu Wencai. Liu Wencai took advantage of the chaos gripping the city to loot around 1.4 million silver dollars, even taking artifacts from the Luzhou Fuzhou Hall. Liu Wencai then escaped, disguised as a foreigner, ending his rule of Yibin. Thus, already caught off-balance, Liu Wenhui lost two of his most important cities at the very start of the war. Liu Xiang's army then began advancing towards Leshan. In November, Liu Wenhui would end up antagonizing the other Baoding warlords by attacking Tian Songyao's forces in Chengdu. The ensuing urban warfare caused over 20,000 casualties and 27,000 refugees, leading to both warlords losing much of their popular support. Deng Xihou, the third Baoding warlord, attempted to mediate the conflict, but with no success. Although Tian Songyao had been defeated by December and even offered to retire, his subordinates refused to let him step down. In the end, a ceasefire was reached and Tian remained in Chengdu, causing no gain for Liu Wenhui, who had departed for Meishan to set up his headquarters.
Patients may be advised to limit alcohol consumption, stop smoking, and practice good dental hygiene. It is also advised for individuals who take bisphosphonates to never allow the tablet to dissolve in the mouth as this causes damage to the oral mucosa.
Within hours of the invasion, Kuwait and US delegations requested a meeting of the UN Security Council, which passed Resolution 660, condemning the invasion and demanding a withdrawal of Iraqi troops. On 3 August 1990, the Arab League passed a resolution, which called for a solution from within the league, and warned against outside intervention. Iraq and Libya were the only Arab League states that opposed the resolution for Iraq to withdraw; the Palestine Liberation Organization (PLO) opposed it as well. Yemen and Jordan – a Western ally which bordered Iraq and relied on the country for economic support – opposed military intervention from non-Arab states. Separately, Sudan, also an Arab League member, aligned itself with Saddam. On 6 August, Resolution 661 placed economic sanctions on Iraq. Resolution 665 followed soon after, which authorized a naval blockade to enforce the sanctions. It said the "use of measures commensurate to the specific circumstances as may be necessary ... to halt all inward and outward maritime shipping in order to inspect and verify their cargoes and destinations and to ensure strict implementation of resolution 661." The US administration had at first been indecisive with an "undertone ... of resignation to the invasion and even adaptation to it as a fait accompli" until the UK's prime minister Thatcher played a powerful role, reminding the President that appeasement in the 1930s had led to war, that Saddam would have the whole Gulf at his mercy along with 65% of the world's oil supply, and famously urging Bush "not to go wobbly".
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
Short transit at ambient temperature is generally tolerated, but long-term storage at room temperature is not recommended. Heat, moisture, and light all accelerate degradation. Cold, dry, dark storage is the conventional choice.